Hui Kong1, Xiao-Ning Zeng, Yi Fan, Song-Tao Yuan, Song Ge, Wei-Ping Xie, Hong Wang, Gang Hu. 1. Department of Respiratory Medicine, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China; Jiangsu Key Laboratory of Neurodegeneration, Department of Pharmacology, Nanjing Medical University, Nanjing, China.
Abstract
AIMS: The predominant expression of aquaporin-4 (AQP4) in the brain implies that this water channel may be involved in a range of brain disorders. This study was designed to investigate the role of AQP4 in the pathogenesis of depression, and related possible biological mechanism. METHODS AND RESULTS: Wild-type (AQP4(+/+) ) and AQP4 knockout (AQP4(-/-) ) mice were given daily subcutaneous injections of corticosterone (20 mg/kg) for consecutive 21 days. Forced swimming test (FST) and tail suspension test (TST) showed longer immobility times in corticosterone-treated AQP4(-/-) genotype, indicating AQP4 knockout exacerbated depressive-like behaviors in mice. Using immunohistological staining, western blot, and enzyme-linked immunosorbent assay (ELISA), we found a significant loss of astrocytes, aggravated downregulation of excitatory amino acid transporter 2 (EAAT2), synapsin-1, and glial cell line-derived neurotrophic factor (GDNF) in the hippocampus of AQP4(-/-) mice. Moreover, even less hippocampal neurogenesis was identified in corticosterone-treated AQP4(-/-) mice in vivo and hippocampus-derived adult neural stem cells (ANSCs) in vitro. CONCLUSIONS: The present findings suggest AQP4 involves the pathogenesis of depression by modulating astrocytic function and adult neurogenesis, highlighting a novel profile of AQP4 as a potential target for the treatment for depression.
AIMS: The predominant expression of aquaporin-4 (AQP4) in the brain implies that this water channel may be involved in a range of brain disorders. This study was designed to investigate the role of AQP4 in the pathogenesis of depression, and related possible biological mechanism. METHODS AND RESULTS: Wild-type (AQP4(+/+) ) and AQP4 knockout (AQP4(-/-) ) mice were given daily subcutaneous injections of corticosterone (20 mg/kg) for consecutive 21 days. Forced swimming test (FST) and tail suspension test (TST) showed longer immobility times in corticosterone-treated AQP4(-/-) genotype, indicating AQP4 knockout exacerbated depressive-like behaviors in mice. Using immunohistological staining, western blot, and enzyme-linked immunosorbent assay (ELISA), we found a significant loss of astrocytes, aggravated downregulation of excitatory amino acid transporter 2 (EAAT2), synapsin-1, and glial cell line-derived neurotrophic factor (GDNF) in the hippocampus of AQP4(-/-) mice. Moreover, even less hippocampal neurogenesis was identified in corticosterone-treated AQP4(-/-) mice in vivo and hippocampus-derived adult neural stem cells (ANSCs) in vitro. CONCLUSIONS: The present findings suggest AQP4 involves the pathogenesis of depression by modulating astrocytic function and adult neurogenesis, highlighting a novel profile of AQP4 as a potential target for the treatment for depression.
Authors: Kurtis I Auguste; Songwan Jin; Kazunori Uchida; Donghong Yan; Geoffrey T Manley; Marios C Papadopoulos; A S Verkman Journal: FASEB J Date: 2006-11-29 Impact factor: 5.191
Authors: R Silva; A R Mesquita; J Bessa; J C Sousa; I Sotiropoulos; P Leão; O F X Almeida; N Sousa Journal: Neuroscience Date: 2007-12-23 Impact factor: 3.590
Authors: Andiara E Freitas; Javier Egea; Izaskun Buendia; Vanessa Gómez-Rangel; Esther Parada; Elisa Navarro; Ana Isabel Casas; Aneta Wojnicz; José Avendaño Ortiz; Antonio Cuadrado; Ana Ruiz-Nuño; Ana Lúcia S Rodrigues; Manuela G Lopez Journal: Mol Neurobiol Date: 2015-05-13 Impact factor: 5.590
Authors: Caren J Blacker; Vincent Millischer; Lauren M Webb; Ada M C Ho; Martin Schalling; Mark A Frye; Marin Veldic Journal: Mol Neuropsychiatry Date: 2019-07-23